Diabetes

Sometimes, the best way for a pharmacist to truly help a patient is to be brutally honest--and not to sugarcoat the truth.

Diabetes has become both an economic and a health crisis. Prevention programs directed at high-risk patients are needed now more than ever.

Diabetes is becoming a significant burden, both in terms of public health and the economy.

Pharmacists must be aware of potentially serious adverse reactions in patients receiving angiotensin- converting enzyme therapy, particularly with the concurrent use of dipeptidly peptidase IV inhibitors.

The management of type 1 and type 2 diabetes is a booming area of research and development, and the pipeline contains many innovative drugs and dosage forms.

Individuals with diabetes should not overlook preventive skin care as part of their diabetes management routine.

Getting patients who have diabetes -- or who are at risk -- to make proactive changes is difficult, but it's not impossible.

Pharmacists should be prepared to offer informed counseling and ongoing support to the increasing numbers of American women who are obese and trying to lose weight.

Cycloset (quick-release formulation of bromocriptine mesylate), a dopamine D2 agonist, is a novel agent recently approved by the FDA for type 2 diabetes mellitus.

Keeping diabetes under control has many benefits, including cutting the risk for cardiovascular events such as coronary artery disease, myocardial infraction, and congestive heart failure.